Skip to main content
. Author manuscript; available in PMC: 2024 Apr 11.
Published in final edited form as: Neuroimage Rep. 2024 Mar 5;4(1):100200. doi: 10.1016/j.ynirp.2024.100200

Table 1.

Demographic and clinical measures and statistics of ANOVA/t-test.

Smokers
Never smokers
F values
Men (n = 36) Women (n = 28) Men (n = 124) Women (n = 74) G × S G main S main
Age 29.7 ± 2.8 30.4 ± 3.1 ± 3.5 31.0 ± 2.5 3.79 0.52 12.6
PC1 1.0 ± 0.9 −0.03 ± 0.9 0.003 ± 1.0 −0.5 ± 0.7 4.72 34.3 36.9
FTND 4.6 ± 0.8 5.1 ± 0.9 / / / / a2.18
Illic 2.1 ± 1.9 1.5 ± 1.6 0.3 ± 0.8 0.2 ± 0.7 1.03 51.3 0.01
Marij 3.8 ± 1.5 2.5 ± 1.8 0.9 ± 1.3 0.8 ± 1.3 5.66 80.7 1.46
PSQI 5.0 ± 2.9 6.2 ± 4.3 4.2 ± 2.6 4.6 ± 2.9 1.50 4.01 3.64
Depr 5.5 ± 4.0 4.7 ± 4.6 3.5 ± 3.4 3.7 ± 3.6 0.87 7.75 0.86
Anxi 5.0 ± 3.2 4.7 ± 3.2 3.1 ± 2.4 3.6 ± 3.0 0.71 12.6 0.002

Note: Values are mean ± SD. F values reflect the interaction and main effects of between-subject ANOVA.

a

Independent-sample t value is presented for FTND in smokers only. G: group; S: sex; PC1: first principal component of drinking metrics; FTND: Fagerström Test for Nicotine Dependence; Illic: times of non-marijuana illicit drug use, including cocaine, hallucinogens, opiates, sedatives, or other; Marij: times of marijuana use; PSQI: Pittsburgh Sleep Quality Index; Depr: Depressive Problems; Anxi: Anxiety Problems. Bold F values represent significant effects at p < 0.05/28 = 0.0018 (correction for multiple comparisons).